BIO-TECHNE CORP. DL-,01/ US09073M1045 /
| 2024-11-07 9:32:50 PM | Chg. -0.500 | Volume | Bid10:00:01 PM | Ask10:00:01 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 70.500EUR | -0.70% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 11.31 bill.EUR | - | - |
Assets
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 108.8000 | 117.1200 | 129.7490 | 132.3620 | 135.1240 | ||||||
| Intangible Assets | 40.6000 | 108.7760 | 292.8390 | 303.1240 | 452.0420 | ||||||
| Long-Term Investments | - | 3.5750 | 0.0000 | - | - | ||||||
| Fixed Assets | - | 393.0780 | 815.0770 | 875.6900 | 1,210.1940 | ||||||
| Inventories | 34.9000 | 38.8470 | 49.5770 | 57.1020 | 60.1510 | ||||||
| Accounts Receivable | 38.2000 | 47.8740 | 70.0340 | 93.3930 | 116.8300 | ||||||
| Cash and Cash Equivalents | 163.8000 | 318.5680 | 54.5320 | 64.2370 | 91.6120 | ||||||
| Current Assets | 409.5000 | 469.4130 | 248.2830 | 253.8910 | 348.0250 | ||||||
| Total Assets | 778.1000 | 862.4910 | 1,063.3600 | 1,129.5810 | 1,558.2190 | ||||||
Liabilities
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 6.2000 | 9.6520 | 13.4430 | 20.6530 | 16.8560 | ||||||
| Long-term debt | - | 6.9970 | 73 | 91.5000 | 343.7710 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 18.4000 | 33.8000 | 61.4000 | 62.8000 | 120.6000 | ||||||
| Liabilities | 40.6000 | 67.2260 | 216.4250 | 250.3010 | 608.5920 | ||||||
| Share Capital | - | 1.4800 | 1.4840 | 1.4880 | 1.4960 | ||||||
| Total Equity | 737.5000 | 795.2650 | 846.9350 | 879.2800 | 949.6270 | ||||||
| Minority Interests | 0.0000 | - | - | - | - | ||||||
| Total liabilities equity | 778.1000 | 862.4910 | 1,063.3600 | 1,129.5810 | 1,558.2190 | ||||||
Income Statement
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 310.6000 | 357.7630 | 452.2460 | 499.0230 | 563.0030 | ||||||
| Depreciation (total) | - | 19.1750 | 37.2260 | 42.7640 | 60.0360 | ||||||
| Operating Result | 158.5000 | 159.7500 | .1470 | 150.5930 | 120.5840 | ||||||
| Interest Income | 2.6000 | 2.6840 | -.9100 | -1.4990 | -7.0570 | ||||||
| Income Before Taxes | 160.7000 | 161.3920 | 154.1620 | 147.4810 | 111.9610 | ||||||
| Income Taxes | 48.1000 | 50.4440 | 46.4270 | 43.0050 | 35.8750 | ||||||
| Minority Interests Profit | 0.0000 | - | - | - | - | ||||||
| Net Income | 112.6000 | 110.9480 | 107.7350 | 104.4760 | 76.0860 | ||||||
Per Share
Cash Flow
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 123.6000 | 136.7620 | 139.3590 | 143.8700 | 143.4480 | ||||||
| Cash Flow from Investing Activities | -31.2000 | 49.6880 | -426.4930 | -107.5700 | -305.9540 | ||||||
| Cash Flow from Financing | -44.7000 | -36.8060 | 31.2760 | -23.0830 | 189.3860 | ||||||
| Decrease / Increase in Cash | 47.1000 | 154.7820 | -264.0360 | 9.7050 | 27.3750 | ||||||
| Employees | 789 | 967 | 1,356 | 1,560 | 1,800 | ||||||
